Ocugen Inc. Stock Falls Thursday, Underperforms MarketMarketWatch Automated·1 day ago, 04:28 PMOCGN-4.72%
US Equities Wire: Marriott's USD 1B Buyback Highlights Shifting Capital Allocation StrategiesGlobal Report·Jul 22 at 04:18 AMRL+0.51%EVEX-5.37%
Ocugen Inc. Stock Falls Tuesday, Underperforms MarketMarketWatch Automated·Jul 21 at 04:27 PMOCGN-4.72%
The Great AI Infrastructure Pivot Reaches the Fringes of the MarketGlobal Report·Jul 21 at 04:13 AMFGMC0.00%UAA+4.30%
Ocugen Inc. Stock Rises Tuesday, Outperforms MarketMarketWatch Automated·Jul 14 at 04:27 PMOCGN-4.72%
Ocugen Inc. Stock Falls Monday, Underperforms MarketMarketWatch Automated·Jul 13 at 04:28 PMOCGN-4.72%
Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa | OCGN Stock NewsStockTitan·Jul 12 at 10:02 PMOCGN-4.72%